Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Pharmaceutical Care Service in Diabetes (IMPACT4-DM)

2. november 2016 opdateret af: Jeong-Hyun Yoon, Pusan National University

Impact of Pharmaceutical Care Service for Type 2 Diabetes Mellitus Patients in Korea

The purpose of this study is to examine the effectiveness of pharmaceutical care service in the management of poorly controlled type 2 diabetes mellitus.

Studieoversigt

Status

Afsluttet

Intervention / Behandling

Undersøgelsestype

Interventionel

Tilmelding (Faktiske)

257

Fase

  • Ikke anvendelig

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

20 år til 75 år (Voksen, Ældre voksen)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Beskrivelse

Inclusion Criteria: Patients who visit Endocrinology and Metabolism department of Pusan National University Hospital, are with type 2 diabetes mellitus, and meet one of the following criteria

  • Who are diagnosed with type 2 diabetes mellitus for the first time
  • Who need the education for medication or disease
  • Who are with poorly controlled blood glucose
  • Who have poor medication adherence
  • Who have been hospitalized with diabetes complication or poorly controlled blood glucose
  • Whose physician recommend the pharmaceutical care to them

Exclusion Criteria: Patients who meet one of the following criteria

  • Who are with gestational diabetes
  • Who are not able to respond to questionnaires
  • Who are with severe condition such as cerebrovascular disease, mental disorder, and acquired immune deficiency syndrome
  • Who are not able to be followed-up during 9 months in Pusan National University Hospital

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Sundhedstjenesteforskning
  • Tildeling: Randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Enkelt

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Eksperimentel: Pharmaceutical care
Participants received systematically organized pharmaceutical care services, which were provided by pharmacists, in addition to the usual care. The usual care includes traditional consultation with pharmacists as well as traditional medical services provided by physicians, nurses, and dietitian.
Outpatient drug history management, drug regimen review, patient counseling and education before and/or after physician evaluation on the day of facility visit
Andre navne:
  • Pharmaceutical service
Ingen indgriben: Usual care
Participants received the usual care, which includes traditional consultation with pharmacists as well as traditional medical services provided by physicians, nurses, and dietitian.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Medications knowledge at 9 months
Tidsramme: 9 months
Patients' knowledge about diabetes medications was measured by an instrument. The instrument includes items such as the name of medication, mechanism of action, dosage, and side effects.
9 months

Sekundære resultatmål

Resultatmål
Tidsramme
HbA1c level at 9 months
Tidsramme: 9 months
9 months
Random blood glucose level at 9 months
Tidsramme: 9 months
9 months
Blood pressure at 9 months
Tidsramme: 9 months
9 months
Cholesterol level at 9 months
Tidsramme: 9 months
9 months
Proportion of participants taking statins 9 months
Tidsramme: 9 months
9 months
Proportion of participants managing diabetes complications at 9 months
Tidsramme: 9 months
9 months
Morisky Medication Adherence Scale at 9 months
Tidsramme: 9 months
9 months
5-level version of the EQ-5D at 9 months
Tidsramme: 9 months
9 months
EQ Visual Analogue Scale at 9 months
Tidsramme: 9 months
9 months
Problem Areas In Diabetes-Korean questionnaire at 9 months
Tidsramme: 9 months
9 months
Patient Satisfaction Questionnaire-Korean at 9 months
Tidsramme: 9 months
9 months
Cost-effectiveness of pharmaceutical care at 9 months
Tidsramme: 9 months
9 months

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart

1. januar 2015

Primær færdiggørelse (Faktiske)

1. maj 2016

Studieafslutning (Faktiske)

1. juni 2016

Datoer for studieregistrering

Først indsendt

26. oktober 2016

Først indsendt, der opfyldte QC-kriterier

2. november 2016

Først opslået (Skøn)

4. november 2016

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Skøn)

4. november 2016

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

2. november 2016

Sidst verificeret

1. november 2016

Mere information

Begreber relateret til denne undersøgelse

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner